The Global Anti Cathepsin B Market
The Global Anti Cathepsin B Market Size is forecast to grow from USD 199.8Million in 2025 to approximately USD 274.6 Million by 2035. According to Decision Advisors, a detailed research report on the anti cathepsin b market indicates that the increasing use of cathepsin B–targeted antibodies in oncology research trend dominates the market, accounting for approximately 46.5-47.5% of the total share globally. Thermo Fisher Scientific leads the market with an estimated 12-18% global market share. The company reported a 2025 revenue of approximately USD 43-45 Billion, making it one of the most influential forces shaping industry trends and overall market growth.